These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 9851786
1. The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency. Juul A, Møller S, Mosfeldt-Laursen E, Rasmussen MH, Scheike T, Pedersen SA, Kastrup KW, Yu H, Mistry J, Rasmussen S, Müller J, Henriksen J, Skakkebaek NE. J Clin Endocrinol Metab; 1998 Dec; 83(12):4408-15. PubMed ID: 9851786 [Abstract] [Full Text] [Related]
2. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG. J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159 [Abstract] [Full Text] [Related]
3. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life. Aguiar-Oliveira MH, Gill MS, de A Barretto ES, Alcântara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE. J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659 [Abstract] [Full Text] [Related]
4. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3. Juul A, Kastrup KW, Pedersen SA, Skakkebaek NE. J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596 [Abstract] [Full Text] [Related]
5. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. Juul A, Holm K, Kastrup KW, Pedersen SA, Michaelsen KF, Scheike T, Rasmussen S, Müller J, Skakkebaek NE. J Clin Endocrinol Metab; 1997 Aug; 82(8):2497-502. PubMed ID: 9253324 [Abstract] [Full Text] [Related]
6. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3. Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, Barreca A. J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491 [Abstract] [Full Text] [Related]
7. Acid-labile subunit in growth hormone excess and deficiency in adults: evaluation of its diagnostic value in comparison with insulin-like growth factor (IGF)-I and IGF-binding protein-3. Fukuda I, Hizuka N, Itoh E, Yasumoto K, Ishikawa Y, Murakami Y, Sata A, Takano K. Endocr J; 2002 Jun; 49(3):379-86. PubMed ID: 12201224 [Abstract] [Full Text] [Related]
8. The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children. Mandel SH, Moreland E, Rosenfeld RG, Gargosky SE. Endocrine; 1997 Dec; 7(3):351-60. PubMed ID: 9657073 [Abstract] [Full Text] [Related]
9. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency. Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K. J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263 [Abstract] [Full Text] [Related]
10. Diagnostic Value of Serum Acid-Labile Subunit Alone and in combination with IGF-I and IGFBP-3 in the Diagnosis of Growth Hormone Deficiency. Ertl DA, Chen J, Gleiss A, Janu D, Sagmeister S, Raimann A, Riedl S, Haeusler G. Horm Res Paediatr; 2020 Jan; 93(6):371-379. PubMed ID: 33341813 [Abstract] [Full Text] [Related]
11. Acid-labile subunit of human insulin-like growth factor-binding protein complex: measurement, molecular, and clinical evaluation. Khosravi MJ, Diamandi A, Mistry J, Krishna RG, Khare A. J Clin Endocrinol Metab; 1997 Dec; 82(12):3944-51. PubMed ID: 9398693 [Abstract] [Full Text] [Related]
12. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess. Wiesli P, Zwimpfer C, Zapf J, Schmid C. Acta Obstet Gynecol Scand; 2006 Dec; 85(8):900-5. PubMed ID: 16862465 [Abstract] [Full Text] [Related]
13. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. Juul A, Skakkebaek NE. J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120 [Abstract] [Full Text] [Related]
14. Primary acid-labile subunit deficiency due to recessive IGFALS mutations results in postnatal growth deficit associated with low circulating insulin growth factor (IGF)-I, IGF binding protein-3 levels, and hyperinsulinemia. Heath KE, Argente J, Barrios V, Pozo J, Díaz-González F, Martos-Moreno GA, Caimari M, Gracia R, Campos-Barros A. J Clin Endocrinol Metab; 2008 May; 93(5):1616-24. PubMed ID: 18303074 [Abstract] [Full Text] [Related]
15. The acid-labile subunit of human ternary insulin-like growth factor-binding protein complex in girls with central precocious puberty before and during gonadotropin-releasing hormone analog therapy. Cisternino M, Draghi M, Lauriola S, Scarcella D, Bernasconi S, Cavallo L, De Luca F, Lomeo A, Tatò L. J Clin Endocrinol Metab; 2002 Oct; 87(10):4629-33. PubMed ID: 12364447 [Abstract] [Full Text] [Related]
16. Acid-labile subunit (ALS) measurements in children. Nimura A, Katsumata N, Horikawa R, Tanae A, Tanaka T. Endocr J; 2000 Mar; 47 Suppl():S111-4. PubMed ID: 10890197 [Abstract] [Full Text] [Related]
17. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans. Olivecrona H, Hilding A, Ekström C, Barle H, Nyberg B, Möller C, Delhanty PJ, Baxter RC, Angelin B, Ekström TJ, Tally M. J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415 [Abstract] [Full Text] [Related]
18. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism. Schmid C, Zwimpfer C, Brändle M, Krayenbühl PA, Zapf J, Wiesli P. Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519 [Abstract] [Full Text] [Related]
19. The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults. Aimaretti G, Colao A, Corneli G, Pivonello R, MacCario M, Morrison K, Pflaum CD, Strasburger CJ, Lombardi G, Ghigo E. Clin Endocrinol (Oxf); 1999 Dec; 51(6):771-7. PubMed ID: 10619983 [Abstract] [Full Text] [Related]
20. Evaluation of the components of the insulin-like growth factors system in GH-deficient adults: effects of twelve-month rhGH treatment. Ferrante E, Giavoli C, Porretti S, Vassallo E, Ronchi CL, Lania AG, Beck-Peccoz P, Spada A. Horm Metab Res; 2006 May; 38(5):352-5. PubMed ID: 16718634 [Abstract] [Full Text] [Related] Page: [Next] [New Search]